Candesartan cilexetil and Renal cell carcinoma - a phase IV clinical study of FDA data

Summary:

Renal cell carcinoma is reported as a side effect among people who take Candesartan cilexetil (candesartan cilexetil), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Fosamax, and have Fever.

The phase IV clinical study analyzes which people have Renal cell carcinoma when taking Candesartan cilexetil. It is created by eHealthMe based on reports of 14,487 people who have side effects when taking Candesartan cilexetil from the FDA, and is updated regularly.

What is Candesartan cilexetil?

Candesartan cilexetil has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 15,294 Candesartan cilexetil users. Check the latest studies of Candesartan cilexetil.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 792 drugs and 1,334 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

On May, 01, 2026

14,487 people reported to have side effects when taking Candesartan cilexetil.
Among them, 24 people (0.17%) have Renal cell carcinoma.

Could Candesartan cilexetil cause Renal cell carcinoma?

Among these 24 people:

How long have people been on Candesartan cilexetil when they have Renal cell carcinoma? *

What is the gender of people who have Renal cell carcinoma when taking Candesartan cilexetil? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Renal cell carcinoma when taking Candesartan cilexetil? *

What are other drugs people take besides Candesartan cilexetil? *

What are other side effects people have besides Renal cell carcinoma? *

Disease Progression: 9 people, 37.50%
Fever: 7 people, 29.17%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 29.17%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 25.00%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 6 people, 25.00%
Shunt Infection: 6 people, 25.00%
Hair Loss: 4 people, 16.67%
Lipase Increased: 4 people, 16.67%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 4 people, 16.67%
Pleural Effusion (water on the lungs): 3 people, 12.50%

What are the existing conditions these people have? *

Fever: 6 people, 25.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.33%
Gastritis (inflammation of stomach): 2 people, 8.33%
Type 2 Diabetes: 1 person, 4.17%
Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 1 person, 4.17%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 4.17%
Depression: 1 person, 4.17%
Diabetes: 1 person, 4.17%
Hepatocellular Carcinoma (liver cancer): 1 person, 4.17%
Lacunar Infarction (a type of stroke): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Candesartan cilexetil and have Renal cell carcinoma?

- Check whether Renal cell carcinoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Candesartan cilexetil:

Candesartan cilexetil (15,294 reports)

Browse all side effects of Candesartan cilexetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal cell carcinoma:

Renal cell carcinoma (792 drugs)

Browse all the conditions that are associated with Renal cell carcinoma:

Renal cell carcinoma (1,334 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Candesartan cilexetil) and Candesartan cilexetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.